Bone Biologics raises $2.1M via exercise of warrants, issues new warrants for 1.56M shares

Bone Biologics Corp

Existing warrant holders exercised 781,251 shares at $2.43/share, yielding ~$2.1M gross proceeds.
Company issued new unregistered warrants to purchase 1,562,502 shares at $2.00/share (five-year and 18-month terms).
H.C. Wainwright acted as exclusive placement agent; fees include 7.0% cash fee and placement agent warrants.
Net proceeds to fund clinical trials, patent portfolio, and working capital.
Inducement transaction expected to close August 2, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.